Oxitocina Cd Pharma (Oxytocin)

Oxytocin, the active ingredient in Oxitocina Cd Pharma, is a peptide hormone presented as a nasal formulation for obstetric use. It helps induce uterine contractions during labor and supports postpartum hemorrhage management in women. GNH USA supplies Oxitocina Cd Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Oxitocina Cd Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Oxitocina Cd Pharma is a uterotonic agent that acts on the uterine smooth muscle to promote contraction.

- Induction of labor: Facilitates the onset of uterine contractions in term pregnancies when labor needs to be initiated. - Management of postpartum hemorrhage: Enhances uterine tone after delivery to reduce bleeding. - Induction of abortion: Assists in uterine evacuation in the context of a medically supervised termination. - Control of uterine atony: Restores muscle tone when the uterus fails to contract adequately after childbirth. - Support for incomplete miscarriage: Aids in expelling retained products of conception under clinical supervision. - Prevention of prolonged labor and birth‑related complications : Helps maintain adequate contraction patterns through the second stage of labor.

Oxytocin nasal spray may result in a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: Mild stomach upset often reported during initial dosing. - Headache: Transient headache that may accompany uterine stimulation. - Nasal irritation: Local discomfort or burning sensation at the application site. - Flushing: Warmth or reddening of the skin, typically short‑lived. - Dizziness : Occ   t   g  ",